HK1208453A1 - Substituted pyridopyrimidine compounds and their use as flt3 inhibitors flt3 - Google Patents
Substituted pyridopyrimidine compounds and their use as flt3 inhibitors flt3Info
- Publication number
- HK1208453A1 HK1208453A1 HK15109075.2A HK15109075A HK1208453A1 HK 1208453 A1 HK1208453 A1 HK 1208453A1 HK 15109075 A HK15109075 A HK 15109075A HK 1208453 A1 HK1208453 A1 HK 1208453A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- flt3
- inhibitors
- substituted pyridopyrimidine
- pyridopyrimidine compounds
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/305—Mercury compounds
- A61K31/31—Mercury compounds containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261614274P | 2012-03-22 | 2012-03-22 | |
| PCT/US2013/032575 WO2013142382A1 (en) | 2012-03-22 | 2013-03-15 | Substituted pyridopyrimidine compounds and their use as flt3 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1208453A1 true HK1208453A1 (en) | 2016-03-04 |
Family
ID=49223277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15109075.2A HK1208453A1 (en) | 2012-03-22 | 2015-09-16 | Substituted pyridopyrimidine compounds and their use as flt3 inhibitors flt3 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8877763B2 (sv) |
| EP (1) | EP2828259B1 (sv) |
| JP (1) | JP6101341B2 (sv) |
| KR (1) | KR102011770B1 (sv) |
| CN (1) | CN104428298B (sv) |
| AU (1) | AU2013235344B2 (sv) |
| BR (1) | BR112014023460B1 (sv) |
| CA (1) | CA2868156C (sv) |
| CL (1) | CL2014002505A1 (sv) |
| EA (1) | EA031267B1 (sv) |
| ES (1) | ES2694223T3 (sv) |
| HK (1) | HK1208453A1 (sv) |
| IL (1) | IL234802B (sv) |
| IN (1) | IN2014MN02082A (sv) |
| MX (1) | MX360912B (sv) |
| MY (1) | MY184858A (sv) |
| NZ (1) | NZ700283A (sv) |
| PL (1) | PL2828259T3 (sv) |
| SG (1) | SG11201405942RA (sv) |
| TR (1) | TR201816480T4 (sv) |
| WO (1) | WO2013142382A1 (sv) |
| ZA (1) | ZA201407588B (sv) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201602566XA (en) * | 2013-10-21 | 2016-05-30 | Genosco | Substituted pyrimidine compounds and their use as syk inhibitors |
| HUE046008T2 (hu) * | 2014-07-17 | 2020-02-28 | Sunshine Lake Pharma Co Ltd | I-(5-terc-butil)-izoxazol-3-il)-3-(4-((feniI)-etinil)-fenil)-kabamid származékok, valamint az ezekkel rokon vegyületek FLT-3 inhibitorokként rák kezelésére |
| KR20160035411A (ko) * | 2014-09-23 | 2016-03-31 | 주식회사 오스코텍 | LRRK2 (Leucine Rich Repeat Kinase 2) 키나제 억제제로서의 피리도피리미딘 유도체 화합물 |
| CA2967943A1 (en) | 2014-11-17 | 2016-05-26 | Rhode Island Hospital | Nanomaterial compositions, synthesis, and assembly |
| US20210275532A1 (en) * | 2018-06-27 | 2021-09-09 | Oscote Inc. | Pyridopyrimidinone derivatives for use as axl inhibitors |
| KR20200022712A (ko) * | 2018-08-23 | 2020-03-04 | 주식회사 오스코텍 | 8-브로모-2-(1-메틸피페리딘-4-일아미노)-4-(4-페녹시페닐아미노)피리도[4,3-d]피리미딘-5(6H)-온 염산염의 결정다형체 및 그 제조방법 |
| KR102230721B1 (ko) | 2019-02-01 | 2021-03-22 | 주식회사 오스코텍 | 피리도피리미딘계 염산염을 포함하는 경구용 고형제제 및 이의 제조방법 |
| AU2020242287A1 (en) | 2019-03-21 | 2021-09-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | A Dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| CN110327347B (zh) * | 2019-08-16 | 2021-06-01 | 陕西科技大学 | G-749在制备抗真菌药物中的应用 |
| TWI759829B (zh) * | 2019-08-23 | 2022-04-01 | 財團法人生物技術開發中心 | 作為第iii型受體酪胺酸激酶抑制劑之雜環吡唑衍生物 |
| CN114761006A (zh) | 2019-11-08 | 2022-07-15 | Inserm(法国国家健康医学研究院) | 对激酶抑制剂产生耐药性的癌症的治疗方法 |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| WO2023027966A1 (en) | 2021-08-24 | 2023-03-02 | Biomea Fusion, Inc. | Pyrazine compounds as irreversible inhibitors of flt3 |
| EP4370506A1 (en) | 2021-12-30 | 2024-05-22 | Biomea Fusion, Inc. | Pyrazine compounds as inhibitors of flt3 |
| WO2023225005A1 (en) | 2022-05-17 | 2023-11-23 | Biomea Fusion, Inc. | Flt3 combination therapy for cancer and compositions therefor |
| KR102440707B1 (ko) | 2022-07-10 | 2022-09-05 | 이우미 | 공장 추천 시스템 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003523358A (ja) * | 2000-01-27 | 2003-08-05 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 神経変性疾患の治療のためのピリドピリミジノン誘導体 |
| CA2420122A1 (en) * | 2000-08-31 | 2002-03-07 | F. Hoffmann-La Roche Ag | 7-oxo pyridopyrimidines |
| WO2002018380A1 (en) * | 2000-08-31 | 2002-03-07 | F. Hoffmann-La Roche Ag | 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation |
| EP2025678A1 (en) * | 2007-08-17 | 2009-02-18 | Oncalis AG | Pyrazolo[3,4-d]pyrimidine compounds and their use as modulators of protein kinase |
| TW200942537A (en) * | 2008-02-01 | 2009-10-16 | Irm Llc | Compounds and compositions as kinase inhibitors |
| US8383635B2 (en) * | 2008-08-12 | 2013-02-26 | Glaxosmithkline Llc | Chemical compounds |
| US8338481B2 (en) * | 2009-01-28 | 2012-12-25 | Ramot At Tel-Aviv University Ltd. | Alkoxyalkyl S-prenylthiosalicylates for treatment of cancer |
| CN102470127A (zh) * | 2009-08-19 | 2012-05-23 | 埃姆比特生物科学公司 | 联芳基化合物和其使用方法 |
| KR101690358B1 (ko) * | 2009-10-29 | 2017-01-09 | 제노스코 | 키나아제 억제제 |
-
2013
- 2013-03-15 MX MX2014011354A patent/MX360912B/es active IP Right Grant
- 2013-03-15 US US13/841,827 patent/US8877763B2/en active Active
- 2013-03-15 KR KR1020147029509A patent/KR102011770B1/ko active IP Right Grant
- 2013-03-15 EP EP13763998.5A patent/EP2828259B1/en active Active
- 2013-03-15 NZ NZ700283A patent/NZ700283A/en unknown
- 2013-03-15 ES ES13763998.5T patent/ES2694223T3/es active Active
- 2013-03-15 EA EA201491747A patent/EA031267B1/ru not_active IP Right Cessation
- 2013-03-15 MY MYPI2014702705A patent/MY184858A/en unknown
- 2013-03-15 WO PCT/US2013/032575 patent/WO2013142382A1/en active Application Filing
- 2013-03-15 CN CN201380025782.8A patent/CN104428298B/zh active Active
- 2013-03-15 TR TR2018/16480T patent/TR201816480T4/tr unknown
- 2013-03-15 BR BR112014023460-4A patent/BR112014023460B1/pt active IP Right Grant
- 2013-03-15 PL PL13763998T patent/PL2828259T3/pl unknown
- 2013-03-15 JP JP2015501823A patent/JP6101341B2/ja active Active
- 2013-03-15 SG SG11201405942RA patent/SG11201405942RA/en unknown
- 2013-03-15 CA CA2868156A patent/CA2868156C/en active Active
- 2013-03-15 IN IN2082MUN2014 patent/IN2014MN02082A/en unknown
- 2013-03-15 AU AU2013235344A patent/AU2013235344B2/en active Active
-
2014
- 2014-09-22 CL CL2014002505A patent/CL2014002505A1/es unknown
- 2014-09-22 IL IL234802A patent/IL234802B/en active IP Right Grant
- 2014-10-20 ZA ZA2014/07588A patent/ZA201407588B/en unknown
-
2015
- 2015-09-16 HK HK15109075.2A patent/HK1208453A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2868156C (en) | 2020-07-28 |
| EP2828259A1 (en) | 2015-01-28 |
| PL2828259T3 (pl) | 2019-02-28 |
| NZ700283A (en) | 2016-08-26 |
| US8877763B2 (en) | 2014-11-04 |
| TR201816480T4 (tr) | 2018-11-21 |
| JP2015510942A (ja) | 2015-04-13 |
| EA031267B1 (ru) | 2018-12-28 |
| CL2014002505A1 (es) | 2015-10-02 |
| CN104428298A (zh) | 2015-03-18 |
| SG11201405942RA (en) | 2014-10-30 |
| MY184858A (en) | 2021-04-27 |
| KR20140144709A (ko) | 2014-12-19 |
| IN2014MN02082A (sv) | 2015-08-21 |
| KR102011770B1 (ko) | 2019-08-19 |
| CN104428298B (zh) | 2017-03-01 |
| JP6101341B2 (ja) | 2017-03-22 |
| US20130274274A1 (en) | 2013-10-17 |
| ES2694223T3 (es) | 2018-12-19 |
| EP2828259A4 (en) | 2015-08-19 |
| MX2014011354A (es) | 2014-12-05 |
| CA2868156A1 (en) | 2013-09-26 |
| AU2013235344B2 (en) | 2017-03-16 |
| BR112014023460B1 (pt) | 2020-09-01 |
| AU2013235344A1 (en) | 2014-10-09 |
| EA201491747A1 (ru) | 2015-10-30 |
| MX360912B (es) | 2018-11-22 |
| WO2013142382A1 (en) | 2013-09-26 |
| ZA201407588B (en) | 2015-11-25 |
| EP2828259B1 (en) | 2018-08-08 |
| IL234802B (en) | 2018-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1208453A1 (en) | Substituted pyridopyrimidine compounds and their use as flt3 inhibitors flt3 | |
| HRP20151103T1 (en) | Substituted triazolopyridines and their use as ttk inhibitors | |
| EP2920149A4 (en) | 3-AMINOCYCLOALKYL COMPOUNDS AS ROR-GAMMA-T-HEMMER AND USES THEREOF | |
| AP2015008328A0 (en) | Pyrrolotriazinone derivatives as pi3k inhibitors | |
| HK1210771A1 (en) | Azaindole derivatives which act as pi3k inhibitors | |
| ZA201406082B (en) | Use of ccr3-inhibitors | |
| SG11201503977PA (en) | Azaindole derivatives as jak3 inhibitors | |
| HK1206350A1 (en) | 2h-imidazol-4-amine compounds and their use as bace inhibitors 2h--4- bace | |
| HK1212331A1 (en) | 4-carboxamido-isoindolinone derivatives as selective parp-1 inhibitors parp-1 4-- | |
| HK1201270A1 (en) | Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides -5---5-- | |
| HK1208029A1 (en) | Imidazopyridine derivatives | |
| IL239245A0 (en) | A new use of Eclidenium | |
| HK1214244A1 (zh) | 咪唑並吡啶衍生物 | |
| GB201209458D0 (en) | Novel compounds and their use as kinase inhibitors | |
| GB201206048D0 (en) | Novel compounds and their use as kinase inhibitors | |
| GB201213726D0 (en) | Novel compounds and their use |